Entrada Therapeutics adds to board of directors

Entrada Therapeutics has brought on Mary Thistle to its board of directors, where she brings 25 years of experience in finance and strategy, as well as expertise in rare diseases. She currently is special advisor at the Bill & Melinda Gates Medical Research Institute.

Lecia Bushak

May 11, 2021

9:00 am

Entrada Therapeutics has brought on Mary Thistle to its board of directors, where she brings 25 years of experience in finance and strategy, as well as expertise in rare diseases. She currently is special advisor at the Bill & Melinda Gates Medical Research Institute.

From Our Partners

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

Partner Content

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

The evolution of patient needs and rising consumer expectations are shaping a new era in healthcare — one that calls for a paradigm shift in the pharmaceutical industry's approach to patient support.

Omnichannel activation without omniburden

Partner Content

Omnichannel activation without omniburden

Explore solutions for practically implementing omnichannel approaches into your go-to-market activation.

Taking a patient-centric approach to privacy

Partner Content

Taking a patient-centric approach to privacy

This podcast will explore ways to deliver tailored content that activates, educates and empowers patients while prioritizing privacy and consent.

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.